Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Nkarta, Inc. | 146,735 | reported | 15 Jan 2025 | tx 18+756,600−20,065 |
| OncoMed Pharmaceuticals Inc | 0 | reported | 23 Apr 2019 | tx 44+393,552−95,672 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 Jan 2025 | SALE | Nkarta, Inc. | 9,584 | 2.20 USD | |
| 03 Jan 2025 | GRANT_AWARD | Nkarta, Inc. | 52,500 | 0.00 USD | |
| 03 Jan 2025 | GRANT_AWARD | Nkarta, Inc. | 105,000 | 0.00 USD | deriv |
| 16 Jul 2024 | SALE | Nkarta, Inc. | 3,396 | 8.00 USD | |
| 18 Jun 2024 | SALE | Nkarta, Inc. | 727 | 5.60 USD | |
| 16 Jan 2024 | SALE | Nkarta, Inc. | 4,554 | 8.74 USD | |
| 04 Jan 2024 | GRANT_AWARD | Nkarta, Inc. | 56,000 | 0.00 USD | |
| 04 Jan 2024 | GRANT_AWARD | Nkarta, Inc. | 112,500 | 0.00 USD | deriv |
| 20 Jun 2023 | SALE | Nkarta, Inc. | 701 | 4.85 USD | |
| 17 Jan 2023 | SALE | Nkarta, Inc. | 1,103 | 5.49 USD | |
| 13 Jan 2023 | GRANT_AWARD | Nkarta, Inc. | 37,500 | 0.00 USD | |
| 13 Jan 2023 | GRANT_AWARD | Nkarta, Inc. | 75,000 | 0.00 USD | deriv |
| 17 Jun 2022 | GRANT_AWARD | Nkarta, Inc. | 8,000 | 0.00 USD | |
| 17 Jun 2022 | GRANT_AWARD | Nkarta, Inc. | 50,500 | 0.00 USD | deriv |
| 14 Jan 2022 | GRANT_AWARD | Nkarta, Inc. | 12,800 | 0.00 USD | |
| 14 Jan 2022 | GRANT_AWARD | Nkarta, Inc. | 76,800 | 0.00 USD | deriv |
| 14 Jan 2022 | GRANT_AWARD | Nkarta, Inc. | 20,000 | 0.00 USD | deriv |
| 26 Oct 2020 | GRANT_AWARD | Nkarta, Inc. | 150,000 | 0.00 USD | deriv |
| 23 Apr 2019 | TENDER | OncoMed Pharmaceuticals Inc | 39,488 | — | |
| 10 Oct 2018 | SALE | OncoMed Pharmaceuticals Inc | 1,156 | 2.02 USD | |
| 09 Oct 2018 | SALE | OncoMed Pharmaceuticals Inc | 1,686 | 2.13 USD | |
| 24 Apr 2018 | SALE | OncoMed Pharmaceuticals Inc | 4,051 | 2.68 USD | |
| 04 Jan 2018 | GRANT_AWARD | OncoMed Pharmaceuticals Inc | 70,000 | 0.00 USD | deriv |
| 10 Oct 2017 | SALE | OncoMed Pharmaceuticals Inc | 1,202 | 4.24 USD | |
| 10 Oct 2017 | SALE | OncoMed Pharmaceuticals Inc | 46 | 4.26 USD | anomaly |